Blockbuster Humira loses 94 percent of the Danish market in three months

In few months, Denmark's best selling drug, Humira from Abbvie, has nearly disappeared from the Danish hospitals. New biosimilar drugs have stolen market shares at record speed, and Amgros expects to save approximately DKK 400 million (USD 61.18 million) in 2019.

Photo: David J. Phillip/AP

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles